Companies

See how salaries can vary from company to company

We're engineered to be different. Leveraging a patient-care approach, KeyBridge is transforming the patient billing experience. We have pioneered a truly patient-first approach'coupling uncommonly trained patient advocates with custom technology and data-driven processes designed to help patients pay their balances. We are 100% focused on healthcare'servicing providers, hospitals, physician groups, and other medical specialties. KeyBridge has earned a 97% patient satisfaction rating'a metric we measure on every patient call. And we deliver business services with results that lead to fanaticall... view company details

MISSION Kohelet Yeshiva is a warm and embracing Modern Orthodox K-12 yeshiva day school committed to cultivating Bnei and Bnot Torah who think critically and creatively while exuding confidence and compassion. The Elementary and Middle School Divisions, known as Kohelet Yeshiva Lab School and Kohelet Yeshiva Middle School, are committed to utilizing replicable, empirically supported, student-centered methods of pedagogy in order to maximize learning for all students in both Judaic and General Studies and advance the field of Jewish Education. The High School division, known as Kohelet Yeshiva ... view company details

Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. The company develops Dolaflexin, a platform, which is used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not amenable to treat with traditional ADC-based therapies. Its lead product candidate is XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients with ovarian cancer, non small cell lung cancer, and other orphan indicat... view company details

MGIC Investment Corporation, through its subsidiaries, provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services to lenders and government sponsored entities in the United States. The company offers primary mortgage insurance that provides mortgage default protection on individual loans, as well as covers unpaid loan principal, delinquent interest, and various expenses associated with the default and subsequent foreclosure. It also provides contract underwriting services; and other services for the mortgage finance industry, such as analysis o... view company details

Stop researching destinations and just start flying. At Objectstream, we believe in turning thoughts into actions. Here is how we do it: We lead with visionary perspective. Our team of seasoned executives bring both sagacity and youthful energy to the IT consulting industry. We adapt through innovative thought processes. Our Agile development techniques allow us to meet the challenges of today's complex organizational changes. We value resourcefulness, living in the solution, not the problem. We respond with effective solutions. In both private and government sectors, we tailor our products an... view company details

PLx Pharma Inc., a late-stage specialty pharmaceutical company, focuses on developing its PLxGuard delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce acute gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention. Its product pipeline also includes other oral non-steroidal anti-inflammatory drugs using the PLxGuard delivery system, such as PL1200 Ibuprofen 200 mg,... view company details

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics based upon biology and tetracycline chemistry in the United States. Its lead product candidates include omadacycline, an intravenous and oral antibiotic for use as a monotherapy antibiotic for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other community-acquired bacterial infections; and Sarecycline, a tetracycline-derived compound designed for use in the treatment of acne and r... view company details

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States and Europe. Its two lead product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug pr... view company details

Revance Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development, manufacture, and commercialization of novel neuromodulators for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (DAXI), which is in phase III clinical trials to treat glabellar (frown) lines and cervical dystonia; and in phase II clinical trials for the treatment of plantar fasciitis, adult upper limb spasticity, and chronic migraine. It is also developing DAXI for forehead lines and lateral canthal lines; DaxibotulinumtoxinA Topi... view company details

Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic disorders that result in life-threatening metabolic disorders. The company's lead product candidate is setmelanotide, a melanocortin-4 receptor agonist peptide, which is in Phase III clinical trials to treat pro-opiomelanocortin (POMC) and leptin receptor deficiency obesity, and Bardet-Biedl and Alstrom syndrome; and is in Phase II clinical trials for treating POMC heterozygous deficiency obesity and POMC epigenetic disorders. It is also ... view company details

Royal Gold, Inc., together with its subsidiaries, acquires and manages precious metal streams, royalties, and related interests. It focuses on acquiring stream and royalty interests or to finance projects that are in production or in development stage in exchange for stream or royalty interests, which primarily consists of gold, silver, copper, nickel, zinc, lead, cobalt, and molybdenum. As of August 1, 2018, the company owned interests in 191 properties on 6 continents, including interests on 40 producing mines and 18 development stage projects. Its principal producing stream and royalty inte... view company details

SCYNEXIS, Inc., a drug development company, develops and commercializes anti-infectives to address unmet therapeutic needs. It is developing its lead product candidate, SCY-078, as a novel oral and intravenous drug for the treatment of various fungal infections, including serious and life-threatening invasive fungal infections. The company also develops SCY-078, which is in various Phase I studies for the oral and intravenous formulations, as well as has completed Phase II study as a step-down therapy in patients with invasive candidiasis and vulvovaginal candidiasis. It has research collabora... view company details

Synlogic, Inc. a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic medicines to treat metabolic, inflammatory, and cancer diseases in the United States. Its lead therapeutic programs include SYNB1020, an oral therapy for the treatment of hyperammonemia, which includes patients with liver diseases, such as hepatic encephalopathy, as well as patients with urea cycle disorders; and SYNB1618, an oral therapy that is in Phase I/IIa clinical trial to treat phenylketonuria. The company is also developing SYNB1891, an intratumorally administered syn... view company details

ServiceSource International, Inc. operates as a digital customer journey experience company. Its solutions include lead generation, inside sales, outsourced sales operations, customer onboarding, customer success management, cross-sell and upsell, warranty conversion, account-based marketing, and channel recruitment and enablement, as well as renewals management services, such as the sale of maintenance and support service contracts for the products used by its clients' end-users. The company also offers sales performance analysis, business case, pricing and contract structuring, data integrat... view company details

Foamix Pharmaceuticals Ltd., a late clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations for dermatological therapy in the United States, France, Denmark, and Germany. Its lead product candidates include FMX101, a novel topical foam formulation of the antibiotic minocycline that has completed third pivotal Phase III clinical trial for the treatment of moderate-to-severe acne; and FMX103, which is in Phase III clinical trial for the treatment of moderate-to-severe papulopustular rosacea. The company's product pipeline includes FCD105 and FMX109 fo... view company details

Whiteboard Marketing LLC is a full-service sales and marketing consulting firm that provides a strategic partnership alliance with each client we serve. Our services include strategic marketing planning; marketing research internet/inbound marketing; social media campaigns; email strategy; SEO, PPC and SEM programs; media buying and placement; video production, website design, hosting and management; print collateral production and other services that drive sales and brand awareness. At Whiteboard Marketing, we utilize a calculated integration of all of these marketing initiatives to achieve R... view company details

Woods is a leading advocacy and service organization for people with exceptional challenges, disabilities and complex needs. We were founded a century ago by visionary Mollie Woods with two simple goals - to advance the quality of life and standard of care for individuals with disabilities. She gained international recognition for her groundbreaking work in helping children with exceptional needs experience the joy of achievement and lead fulfilling lives. Today, we've broadened her mission to serve people of all ages and levels of care with a unique model, The Exceptional Care Model, that dri... view company details

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of various small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing. The company's lead product candidates for the treatment of CF include PTI-801, a third generation cystic fibrosis transmembrane conductance regulator (CFTR) corrector agent; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. It has collaboration agreements with Cystic Fibrosis Foundation, Inc. to research, develop, and commercialize produc... view company details

For more than 45 years, Acts Retirement-Life Communities has met the retirement lifestyle and healthcare needs of older adults living in our communities. Our company began in 1971 with the vision of a church pastor and his congregation whose goal was to create an environment that offered seniors a rewarding lifestyle and high quality healthcare if ever needed. Today, Acts is the largest not-for-profit owner, operator and developer of continuing care retirement communities (CCRCs) in the United States. Our 26 communities currently serve more than 10,000 residents in nine states. Our vision for ... view company details

W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writer in the United States and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment underwrites commercial insurance business, including premises operations, commercial automobile, property, products liability, and professional liability lines. It also provides workers' compensation, property casualty, general liability, professional liability, and excess and umbrella coverage insurance products, as well as coverages for technology, ambulatory surgery centers,... view company details